THAT — Thalia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Thalia Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.78	1.92	1.03	0.626	1.08
Net Total Receivables	0.551	0.21	0.176	0.135	0.074
Prepaid Expenses
Total Current Assets	2.34	2.17	1.21	0.776	1.17
Net Goodwill
Total Assets	2.34	2.17	1.28	0.776	1.17
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.213	0.078	0.082	0.124	0.098
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.213	0.078	0.148	0.128	0.099
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.13	2.09	1.13	0.648	1.07
Total Liabilities & Shareholders' Equity	2.34	2.17	1.28	0.776	1.17
Total Common Shares Outstanding